Goldman Sachs Group Inc Uni Qure N.V. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Uni Qure N.V. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 323,164 shares of QURE stock, worth $2.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
323,164
Previous 303,450 6.5%
Holding current value
$2.3 Million
Previous $1.36 Million 17.22%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.78 - $10.12 $74,518 - $199,505
19,714 Added 6.5%
323,164 $1.59 Million
Q2 2024

Aug 13, 2024
SELL
$4.39 - $5.43 $258,496 - $319,734
-58,883 Reduced 16.25%
303,450 $1.36 Million
Q1 2024

May 15, 2024
SELL
$4.82 - $6.93 $1.61 Million - $2.31 Million
-333,012 Reduced 47.89%
362,333 $1.88 Million
Q4 2023

Feb 13, 2024
BUY
$5.63 - $8.27 $1.31 Million - $1.93 Million
233,526 Added 50.57%
695,345 $4.71 Million
Q3 2023

May 14, 2024
SELL
$6.71 - $11.83 $1.57 Million - $2.76 Million
-233,526 Reduced 33.58%
461,819 $3.1 Million
Q3 2023

Nov 14, 2023
BUY
$6.71 - $11.83 $190,530 - $335,912
28,395 Added 6.55%
461,819 $3.1 Million
Q2 2023

May 14, 2024
BUY
$11.12 - $22.2 $46,014 - $91,863
4,138 Added 0.96%
433,424 $4.97 Million
Q2 2023

Aug 14, 2023
BUY
$11.12 - $22.2 $46,014 - $91,863
4,138 Added 0.96%
433,424 $4.97 Million
Q1 2023

May 14, 2024
SELL
$18.7 - $23.07 $128,469 - $158,490
-6,870 Reduced 1.58%
429,286 $8.65 Million
Q1 2023

May 11, 2023
SELL
$18.7 - $23.07 $128,469 - $158,490
-6,870 Reduced 1.58%
429,286 $8.65 Million
Q4 2022

May 14, 2024
SELL
$18.12 - $27.32 $621,987 - $937,786
-34,326 Reduced 7.3%
436,156 $9.89 Million
Q4 2022

Feb 13, 2023
SELL
$18.12 - $27.32 $621,987 - $937,786
-34,326 Reduced 7.3%
436,156 $9.89 Million
Q3 2022

May 14, 2024
BUY
$16.98 - $25.54 $1.15 Million - $1.73 Million
67,551 Added 16.76%
470,482 $8.83 Million
Q3 2022

Nov 10, 2022
BUY
$16.98 - $25.54 $1.15 Million - $1.73 Million
67,551 Added 16.76%
470,482 $8.83 Million
Q2 2022

May 14, 2024
SELL
$13.15 - $20.45 $3.85 Million - $5.98 Million
-292,414 Reduced 42.05%
402,931 $7.51 Million
Q2 2022

Aug 15, 2022
BUY
$13.15 - $20.45 $1.32 Million - $2.05 Million
100,241 Added 33.12%
402,931 $7.51 Million
Q1 2022

May 16, 2022
SELL
$14.54 - $21.5 $203,080 - $300,290
-13,967 Reduced 4.41%
302,690 $5.47 Million
Q4 2021

Feb 14, 2022
SELL
$20.24 - $36.01 $5.16 Million - $9.19 Million
-255,112 Reduced 44.62%
316,657 $6.57 Million
Q3 2021

Nov 10, 2021
BUY
$26.01 - $38.22 $14.9 Million - $21.9 Million
571,769 New
571,769 $18.3 Million

Others Institutions Holding QURE

# of Institutions
154
Shares Held
41M
Call Options Held
925K
Put Options Held
617K
View Full List

About uniQure N.V.

QURE Quotes by TradingView
  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $333M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email